Lescol and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lescol (fluvastatin sodium) and Neupogen (filgrastim). Common drug interactions include breast cancer recurrent among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Lescol and Neupogen. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Lescol?

Lescol has active ingredients of fluvastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 7,306 Lescol users. Check the latest studies of Lescol.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

On Jul, 11, 2026

20 people who take Lescol and Neupogen together, and have interactions are studied.

What are the common drug interactions of Lescol and Neupogen, by gender? *:

female:

Breast cancer recurrent
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Fistula (an abnormal connection or passageway between two)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Impaired healing
Inflammation
Oral disorder (mouth disease)
Osteosarcoma metastatic (a cancerous (malignant) bone tumour can spreads to other parts)
Pain in jaw
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

male:

Pyrexia (fever)
Acute pulmonary oedema (sudden deposit of fluid in the lung))
Renal failure acute (rapid kidney dysfunction)
Acute sinusitis
Anaemia (lack of blood)
Aortic arteriosclerosis (hardening of the aortic arteries)
Aortic valve incompetence
Aortic valve sclerosis (narrowing of the aortic valve)
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Ascites (accumulation of fluid in the abdominal cavity)

What are the common drug interactions of Lescol and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Atelectasis (partial or complete collapse of the lung)
Atrioventricular block first degree (heart block first degree)
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Back pain
Bacterial infection
Bone fragmentation
Bone marrow failure
Bone pain

20-29:

n/a

30-39:

n/a

40-49:

Febrile neutropenia (fever with reduced white blood cells)

50-59:

Acute sinusitis
Bone marrow failure
Bone neoplasm malignant (cancer of bone)
Bone pain
Breast cancer recurrent
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Fistula (an abnormal connection or passageway between two)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Impaired healing
Inflammation

60+:

Acute pulmonary oedema (sudden deposit of fluid in the lung))
Cardiac failure congestive
Blood pressure decreased
Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
Cardiac arrest
Chills (felling of cold)
Dementia (madness)
General physical health deterioration (weak health status)
Haemoglobin decreased
Hypertension (high blood pressure)

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 11 people, 55.00%
High Blood Pressure: 10 people, 50.00%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 3 people, 15.00%
T-Cell Lymphoma Stage Iv (one or more organs beyond the lymph nodes are affected with cancer of lymph node): 1 person, 5.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 5.00%
Nausea And Vomiting: 1 person, 5.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.00%
Metastases To Bone (cancer spreads to bone): 1 person, 5.00%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 5.00%
Hypersensitivity: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lescol and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously